At SEGOVA New Generation, our mission is to connect patients with leading European experts and evidence-based therapies in the field of regenerative reproductive medicine. A recently published scientific review entitled

International Journal of Molecular Sciences MDPI

Published in the prestigious International Journal of Molecular Sciences. A new article on the DOS (Dual Ovarian Stem Cell Therapy) method, featuring an overview of the most advanced treatment technologies

Non binary IVF patiens

Published in the Journal of Perinatal Medicine. A few months ago, Professor Ljubić’s team published an article in the prestigious European journal, the Journal of Perinatal Medicine, exploring the specificities

Mesenchymal and hematopoietic stem cells in ovarian rejuvenation

Published in the journal Investigations in Gynecology Research & Women’s Health. Professor Ljubić’s team recently published an original method for ovarian rejuvenation — DOS – Dual Ovarian Stem cell Therapy)

Prof. Ljubic at International Congress of Reproductive Medicine 2024 in Doha

Professor Ljubić presented a groundbreaking new technology in regenerative medicine at the International Congress of Reproductive Medicine 2024 in Doha, Qatar. The innovation involves the use of two types of

Natural VS stimulated IVF cycle in segova

Professor Aleksandar Ljubić comments on the artist Kristina Varaksina’s image. Natural IVF cycle vs stimulated IVF cycle for a more human-centric approach! The powerful image of a woman with a

New Generation of the Segova method

Professor Ljubic and his team have developed innovations in the ovaries and testes regeneration programme. SEGOVA New Generation (NG) is the most complete, available medical biotechnological programme for rejuvenating and

The Role of Cell and Gene Therapies in the Treatment of Infertility in Patients with Thyroid Autoimmunity

Published in International Journal of Endocrinology Abstract There is a rising incidence of infertility worldwide, and many couples experience difficulties conceiving nowadays. Thyroid autoimmunity (TAI) is recognized as one of

ovarian In vitro tissue activation

Published in International Journal of Fertility and Sterility Abstract Background: Premature ovarian failure (POF) can be found in 1% of women at the age of 35-40, mostly due to unknown

Most popular posts

human embryo in the womb

Published in Implantation and the Fetal Health. Induced Abortion and Spontaneous Early Pregnancy Loss – Focus on Management Abstract Implantation is one of the crucial periods in human reproduction. Increasing

in vitro fertilization with the segova team

Besides the Segova program, our team is performing very successfully other specific fertility programs which you cannot find at other clinics. Below are listed some of the procedures we perform.

Prof dr Aleksandar Ljubić has lectured at the online conference on the issue of enhancement organized by The Center for the Study of Bioethics The Wellcome Centre for Ethics and